ResMed Inc.
RMD
$255.83
$0.790.31%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 348.54M | 379.71M | 365.04M | 344.62M | 311.36M |
| Total Depreciation and Amortization | 51.27M | 67.94M | 45.65M | 49.50M | 47.25M |
| Total Amortization of Deferred Charges | 6.40M | 6.34M | 6.26M | 6.40M | 6.46M |
| Total Other Non-Cash Items | 25.86M | 26.02M | 29.43M | 23.00M | 19.87M |
| Change in Net Operating Assets | 25.26M | 58.76M | 132.28M | -114.90M | -59.40M |
| Cash from Operations | 457.32M | 538.77M | 578.66M | 308.62M | 325.54M |
| Capital Expenditure | -42.97M | -30.59M | -20.80M | -20.64M | -17.84M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -522.00K | -138.58M | 0.00 | -670.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.09M | 35.45M | -10.99M | -15.38M | 19.99M |
| Cash from Investing | -52.58M | -133.71M | -31.79M | -36.69M | 2.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -5.00M | 0.00 | -5.00M | -30.00M |
| Issuance of Common Stock | 8.21M | 30.16M | 9.02M | 26.88M | 8.38M |
| Repurchase of Common Stock | -150.73M | -100.60M | -75.39M | -91.72M | -50.39M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -87.75M | -77.59M | -77.70M | -77.70M | -77.89M |
| Other Financing Activities | -- | -10.86M | 0.00 | 0.00 | -855.00K |
| Cash from Financing | -230.27M | -163.89M | -144.07M | -147.54M | -150.76M |
| Foreign Exchange rate Adjustments | -71.00K | 35.57M | 7.96M | -28.81M | 11.07M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.40M | 276.74M | 410.77M | 95.58M | 188.00M |